COVID-19: Vaccines and Therapeutics

New research by the National Institutes of Health has confirmed the safety of blood donation and transfusions from COVID-19. NIH concluded that transfusions’ likelihood of infection transmission is a little over 1 in 100,000, or 0.001%.
Moderna yesterday announced an agreement to use Thermo Fisher Scientific to increase the scale of its COVID-19 vaccine finish/fill sterile manufacturing. The deal will enable production to begin in the third quarter of 2021.
The National Institutes of Health yesterday announced the start of a phase 1/2 clinical trial to investigate the safety and immunogenicity of mixed boosted COVID-19 vaccination regimens.
President Biden today announced a national month of action to mobilize the nation to get vaccinated against COVID-19 before the Fourth of July. The White House’s goal is to get 70% of U.S. adults vaccinated with at least one shot by July Fourth. 
Moderna asked the Food and Drug Administration to grant full approval of its COVID-19 vaccine for people age 18 years and older.
A new study published in the New England Journal of Medicine is confirming Pfizer’s claims of the high levels of effectiveness among adolescents of its COVID-19 vaccine.
The Centers for Disease Control and Prevention recommended clinicians report all cases of inflammation of the heart muscle (myocarditis) or lining (pericarditis) after COVID-19 vaccination to the Vaccine Adverse Event Reporting System, citing an increase since April in cases reported after…
The Health Resources and Services Administration this week announced details on its notice of funding opportunity for its Rural Health Clinic Vaccine Confidence Program.
Hawaii health officials are seeing a decline in the number of residents getting vaccinated against COVID-19, with only 60,000 doses ordered the first week of May. Kaiser Permanente Hawaii is providing $400,000 in funding to increase COVID-19 vaccinations in Hawaii communities disproportionately…